$1.41B
$9,000
0.0% of portfolio
467
Q3 2024
Reduced 39.35%
$5.37B
$17,000
0.0% of portfolio
1,626
Q3 2024
Reduced 97.46%
$0
$597,000
0.0% of portfolio
5,405
Q3 2024
Reduced 83.37%
Kiniksa Pharmaceuticals Intl
-
$0
0.0% of portfolio
-
Q3 2024
Added 0.2%
-
$0
0.0% of portfolio
-
Q1 2022
New
$1.66B
$1,000
0.0% of portfolio
93
Q3 2024
Reduced 53.5%
$0
$1.55 Million
0.0% of portfolio
51,392
Q3 2024
Added 41.82%
$0
$2,000
0.0% of portfolio
90
Q1 2024
Reduced 98.99%
$4.15B
$13,000
0.0% of portfolio
202
Q3 2024
Reduced 0.49%
$21M
$0
0.0% of portfolio
220
Q3 2022
New
$0
$2.68 Million
0.0% of portfolio
10,085
Q3 2024
Reduced 0.16%
$0
$36,000
0.0% of portfolio
500
Q3 2024
Reduced 16.67%
$0
$130,000
0.0% of portfolio
3,722
Q3 2024
Reduced 4.81%
-
$0
0.0% of portfolio
-
Q2 2024
New
$2.33B
$6,000
0.0% of portfolio
7,150
Q3 2024
Reduced 94.89%
$0
$2.74 Million
0.0% of portfolio
57,871
Q3 2024
Added 0.7%
$143M
$0
0.0% of portfolio
1
Q3 2024
New
$6.85B
$0
0.0% of portfolio
2
Q3 2024
Reduced 99.64%
$2.37B
$2,000
0.0% of portfolio
67
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 38.76%
$83.8B
$3.24 Million
0.0% of portfolio
88,486
Q3 2024
Reduced 12.79%
$0
$12,000
0.0% of portfolio
450
Q1 2024
Reduced 79.55%
$10.7B
$56,000
0.0% of portfolio
338
Q3 2024
Reduced 99.73%
Perspective Therapeutics Inc
-
$0
0.0% of portfolio
-
Q3 2024
New
$1.76B
$18,000
0.0% of portfolio
1,626
Q3 2024
Added 984.0%
-
$0
0.0% of portfolio
-
Q3 2024
Added 0.51%
$1.25B
$3,000
0.0% of portfolio
1,605
Q3 2024
Reduced 58.44%
$7B
$233,000
0.0% of portfolio
3,532
Q3 2024
Reduced 5.86%
$6.11B
$87,000
0.0% of portfolio
198
Q3 2024
Added 1.54%
$284M
$0
0.0% of portfolio
1
Q3 2024
New
$22.3B
$2,000
0.0% of portfolio
90
Q3 2024
Reduced 28.0%
$0
$170,000
0.0% of portfolio
1,367
Q3 2024
Added 92.54%
$722M
$0
0.0% of portfolio
1
Q3 2024
New
$3.94B
$141,000
0.0% of portfolio
6,514
Q3 2024
Added 36.94%
$91.1M
$4,000
0.0% of portfolio
910
Q3 2024
Reduced 82.86%
$0
$22,000
0.0% of portfolio
127
Q1 2024
Reduced 70.26%
$33M
$0
0.0% of portfolio
250
Q1 2024
New
$1.38B
$10,000
0.0% of portfolio
601
Q3 2024
Reduced 8.94%
-
$0
0.0% of portfolio
-
Q3 2024
New
$1.22B
$3,000
0.0% of portfolio
68
Q3 2024
Reduced 94.22%
$0
$567,000
0.0% of portfolio
2,362
Q2 2024
Reduced 41.85%
$1.28B
$8,000
0.0% of portfolio
725
Q3 2024
Added 625.0%
$22.1M
$0
0.0% of portfolio
206
Q4 2021
New
$141M
$23,000
0.0% of portfolio
24,490
Q3 2024
Added 156.44%
$98.5M
$0
0.0% of portfolio
202
Q3 2024
Reduced 89.9%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 5.2%
$1.07B
$0
0.0% of portfolio
1
Q3 2024
New
$6.5B
$0
0.0% of portfolio
21
Q3 2024
Reduced 97.0%
$3.19B
$409,000
0.0% of portfolio
8,905
Q3 2024
Reduced 18.85%
$119M
$0
0.0% of portfolio
1
Q3 2024
New